Shares outstanding decreased 6.1%
Shares outstanding changed -6.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed -6.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Cash & equivalents changed -64.2% from the comparable as-filed period.
Working capital changed -26.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed +691 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -42.3% from the comparable as-filed period.
Cash & equivalents changed -40.8% from the comparable as-filed period.
Capex / revenue changed +322 basis points from the comparable as-filed period.
Operating cash flow changed -23.7% from the comparable as-filed period.
Inventory / revenue changed +580 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.